from these findings it seems legitimate to claim that sulglycotide can be administered concurrently with naproxen to prevent possible gastric injury by the anti-inflammatory agent thanks to its wellknown antiulcer and cytoprotective activity on the gastric mucosa , without any undue interference with the absorption ( hence effectiveness ) of naproxen .
C0038351
gastric
C0017136
gastric mucosa